General
Oxford-AstraZeneca, local COVID vaccines given urgent approval in India
The head of India’s drugs regulator said he had given final approval for the emergency use of two coronavirus vaccines, one developed by AstraZeneca and Oxford University and the other by local company Bharat Biotech.
Key points:
- India’s pharmaceutical regulator approved two COVID-19 vaccines simultaneously
- The Australian Government has ordered 50 million doses of the Oxford-AstraZeneca vaccine
- India’s first round of vaccinations aims to immunise 300 million people against coronavirus
The overall efficacy of the Oxford-AstraZeneca vaccine was 70.42 per cent, while Bharat Biotech’s COVAXIN was “safe and provides a robust immune response”, Drugs Controller General of India, Venugopal G Somani, said.
The British-developed Oxford-AstraZeneca…
Continue Reading
-
Noosa News22 hours agoSunshine Coast shines in tourism awards
-
General22 hours agoNational tax regulator shuts down Coolah firm and bans director after large-scale theft
-
General10 hours agoVote counting begins for Townsville mayoral by-election
-
Noosa News23 hours agoAfter tireless advocacy and a dark history, Australia has a treaty with its First Peoples